WORLD
In a Setback for the European Union's Vaccination Campaign, German Firm CureVac Said That ... - Latest Tweet by Reuters
The latest Tweet by Reuters states, 'In a setback for the European Union's vaccination campaign, German firm CureVac said that its COVID-19 vaccine was only 47% effective in a late-stage trial ...'
In a setback for the European Union's vaccination campaign, German firm CureVac said that its COVID-19 vaccine was only 47% effective in a late-stage trial https://t.co/u8vWBrMzwh pic.twitter.com/OW40vpXyf7— Reuters (@Reuters) June 17, 2021
(The above story first appeared on LatestLY on Jun 17, 2021 10:30 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
